SurgePays (SURG) - P/S ratio

P/S ratio as of November 2026 (TTM): 0.1520

According to SurgePays's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.4912. At the end of 2023 the company had a P/S ratio of 0.6692.

P/S ratio history for SurgePays from 2009 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	0.6692	-1.06%
2022	0.6763	41.71%
2021	0.4773	73.83%
2020	0.2746	-76.95%
2019	1.19	-45.74%
2018	2.19	-95.27%
2017	46.4	900.06%
2016	4.64	-47.6%
2015	8.85	-91.72%
2014	107	18.99%
2013	89.8
2011	518	2104.42%
2010	23.5	-92.66%
2009	320

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Johnson & Johnson JNJ	6.69	4,303.74%	🇺🇸 USA
Novartis NVS	5.35	3,420.71%	🇨🇭 Switzerland
Stryker Corporation SYK	4.80	3,058.72%	🇺🇸 USA
Cooper Companies COO	2.80	1,741.20%	🇺🇸 USA
STAAR Surgical STAA	3.73	2,351.74%	🇺🇸 USA
CONMED CNMD	1.12	636.14%	🇺🇸 USA
Integra LifeSciences IART	0.6334	316.72%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for SurgePays (SURG)

P/S ratio as of November 2026 (TTM): 0.1520